Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID Collaborates With US Military to Further Develop Handheld Real-time PCR Device

NEW YORK (GenomeWeb) – PositiveID today announced an agreement with the US Special Operations Command Research, Development, and Acquisition Center to further develop military applications for the company's real-time PCR pathogen detection system, Firefly Dx.

Firefly Dx is a handheld system that can deliver molecular diagnostic results at the point of need using Thermo Fisher Scientific Life Technologies' TaqMan PCR chemistry. It can derive results from a sample in less than 20 minutes, as opposed to two to four hours for a laboratory-based device, the company said in a statement.

Under the agreement, PositiveID will receive requirements, priorities, feedback, and human factors/human systems integration support from USSOCOM as it develops Firefly Dx for applications in Special Operations Forces missions. Financial and other terms of the agreement were not disclosed.

Earlier this year, the Delray Beach, Fla.-based firm signed an agreement with NASA to test Firefly Dx for use in space. The firm eventually plans to move into clinical testing.

PositiveID is focused on developing microfluidic systems for the automated detection and analysis of biological threats and other samples.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.